7:01 am Antares Pharma announces publication of head-to-head, randomized, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis; drug-exposure limitations of oral methotrexate at doses greater than o – HedgeChatter

7:01 am Antares Pharma announces publication of head-to-head, randomized, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis; drug-exposure limitations of oral methotrexate at doses greater than o

21 Apr

7:01 am Antares Pharma announces publication of head-to-head, randomized, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis; drug-exposure limitations of oral methotrexate at doses greater than o

Bystocknews ATRS, stock Comments Off

View todays social media effects on ATRS

View the latest stocks trending across Twitter. Click to view dashboard

See who Antares is hiring next, click here to view

Author